tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

Compare
533 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q3 2024), Amylyx Pharmaceuticals Inc's total revenue was $416.00K, a decrease of -99.59% from the same quarter last year. In Q3, Amylyx Pharmaceuticals Inc's net income was $-72.70M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 380.79M$ 22.23M$ 285.00K$ 650.00K$ 1.43M
Gross Profit
$ 355.35M$ 19.24M$ 233.00K$ -23.94M$ -10.47M
Operating Expenses
$ 316.54M$ 220.58M$ 82.69M$ 39.01M$ 13.55M
Depreciation and Amortization
$ 1.09M$ 487.00K$ 52.00K$ 1.00K$ 13.55M
EBITDA
$ 39.89M$ -200.85M$ -82.64M$ -39.00M$ 1.11M
Operating Income
$ 38.80M$ -201.34M$ -82.69M$ -39.01M$ -13.55M
Other Income/Expenses
$ 15.49M$ 3.74M$ -5.24M$ -3.27M$ -162.00K
Pretax Income
$ 54.30M$ -197.60M$ -87.93M$ -42.28M$ -13.72M
Net Income
$ 49.27M$ -198.38M$ -87.88M$ -44.84M$ -14.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.73$ -2.98$ -1.52$ -0.79$ -0.26
Diluted EPS
$ 0.70$ -2.98$ -1.52$ -0.79$ -0.26
Weighted Average Shares Outstanding
67.23M 66.51M 57.86M 56.47M 56.47M
Weighted Average Shares Outstanding (Diluted)
69.99M 66.51M 57.86M 56.47M 56.47M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis